Table 2.
Effects of chronic systemic SR141716A or vehicle treatment in (mRen2)27 rats
| Parameter | (mRen2)27 Vehicle | (mRen2)27 SR 10 mg/kg/day |
|---|---|---|
| Plasma Ang I (pg/mL) | 353 ± 112 | 302 ± 52 |
| Plasma Ang II (pg/mL) | 71 ± 25 | 69 ± 11 |
| Plasma Ang‐(1–7) (pg/mL) | 45 ± 7 | 46 ± 7 |
| Serum ACE (ng/mL) | 26 ± 2 | 30 ± 4 |
| Urine vasopressin (pg/mL) | ||
| Baseline | 107 ± 12 | 104 ± 16 |
| Day 21 | 100 ± 19 | 110 ± 31 |
| Urine osmolality (mOsm/L) | ||
| Baseline | 1471 ± 107 | 1528 ± 77 |
| Day 21 | 1639 ± 110 | 1809 ± 69** |
Values are mean ± SEM. SR refers to SR141716A.
**P < 0.01 versus Baseline; n = 7–8 all groups.